Table 4.
Knowledge of Canadian general surgeons regarding lymph node harvest, distal resection margin for upper rectal cancer and indications for adjuvant therapy in patients with rectal cancer.
| Factor | Responses by practice region, % | Responses according to surgeon training, % | |||
|---|---|---|---|---|---|
|
|
|
||||
| Atlantic | Central | West | Fellowship* | Others | |
| Surgeons who indicated that ≥ 12 lymph nodes are recommended for staging rectal cancer†‡ | 36 | 61 | 48 | 71 | 51 |
|
| |||||
| Surgeons who indicated that an adequate distal resection margin for upper rectal cancer is ≥ 5 cm‡ | 37 | 46 | 46 | 67 | 41 |
|
| |||||
| Surgeons who would refer patients with stage II/III rectal cancer for adjuvant therapy‡ | 62 | 70 | 70 | 79 | 67 |
*
Colorectal/surgical oncology fellowship.
†
Significant difference across practice regions (p < 0.01).
‡
Significant difference according to fellowship training (p < 0.01).